Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal

Sung Hee Cho, Man Ho Choi, Won Yong Lee, Bong Chul Chung

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Objective: Evaluation of altered urinary nucleosides before and after tumor removal of breast cancer (BCa). Design and methods: Targeted metabolite profiling of 14 urinary nucleosides was conducted with both pre- and post-operative female patients with BCa (n = 150, age: 46.6 ± 7.7 years), and female controls (n = 150, age: 46.8 ± 7.7 years) by liquid chromatography-tandem mass spectrometry coupled to on-line extraction. Results: Levels of modified nucleosides (5-hydroxymethyl-2′-deoxyuridine, P < 0.001; 8-hydroxy-2′-deoxyguanosine, P < 0.001; 1-methyladenosine, P < 0.02; N2,N2-dimethylguanosine, P < 0.001) were significantly higher in pre-operative patients than in both normal controls and post-operative patients. Conclusions: This approach could be used to further understand the pathogenesis of BCa as well as to evaluate the effects of medical treatment.

Original languageEnglish
Pages (from-to)540-543
Number of pages4
JournalClinical Biochemistry
Volume42
Issue number6
DOIs
Publication statusPublished - 2009 Apr 1

Fingerprint

Nucleosides
Tumors
Breast Neoplasms
Neoplasms
Liquid chromatography
Metabolites
Tandem Mass Spectrometry
Liquid Chromatography
Mass spectrometry
Therapeutics

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

Cho, Sung Hee ; Choi, Man Ho ; Lee, Won Yong ; Chung, Bong Chul. / Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal. In: Clinical Biochemistry. 2009 ; Vol. 42, No. 6. pp. 540-543.
@article{3ff1d69492664661b20bc36d09c4ea94,
title = "Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal",
abstract = "Objective: Evaluation of altered urinary nucleosides before and after tumor removal of breast cancer (BCa). Design and methods: Targeted metabolite profiling of 14 urinary nucleosides was conducted with both pre- and post-operative female patients with BCa (n = 150, age: 46.6 ± 7.7 years), and female controls (n = 150, age: 46.8 ± 7.7 years) by liquid chromatography-tandem mass spectrometry coupled to on-line extraction. Results: Levels of modified nucleosides (5-hydroxymethyl-2′-deoxyuridine, P < 0.001; 8-hydroxy-2′-deoxyguanosine, P < 0.001; 1-methyladenosine, P < 0.02; N2,N2-dimethylguanosine, P < 0.001) were significantly higher in pre-operative patients than in both normal controls and post-operative patients. Conclusions: This approach could be used to further understand the pathogenesis of BCa as well as to evaluate the effects of medical treatment.",
author = "Cho, {Sung Hee} and Choi, {Man Ho} and Lee, {Won Yong} and Chung, {Bong Chul}",
year = "2009",
month = "4",
day = "1",
doi = "10.1016/j.clinbiochem.2008.12.026",
language = "English",
volume = "42",
pages = "540--543",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "6",

}

Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal. / Cho, Sung Hee; Choi, Man Ho; Lee, Won Yong; Chung, Bong Chul.

In: Clinical Biochemistry, Vol. 42, No. 6, 01.04.2009, p. 540-543.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal

AU - Cho, Sung Hee

AU - Choi, Man Ho

AU - Lee, Won Yong

AU - Chung, Bong Chul

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Objective: Evaluation of altered urinary nucleosides before and after tumor removal of breast cancer (BCa). Design and methods: Targeted metabolite profiling of 14 urinary nucleosides was conducted with both pre- and post-operative female patients with BCa (n = 150, age: 46.6 ± 7.7 years), and female controls (n = 150, age: 46.8 ± 7.7 years) by liquid chromatography-tandem mass spectrometry coupled to on-line extraction. Results: Levels of modified nucleosides (5-hydroxymethyl-2′-deoxyuridine, P < 0.001; 8-hydroxy-2′-deoxyguanosine, P < 0.001; 1-methyladenosine, P < 0.02; N2,N2-dimethylguanosine, P < 0.001) were significantly higher in pre-operative patients than in both normal controls and post-operative patients. Conclusions: This approach could be used to further understand the pathogenesis of BCa as well as to evaluate the effects of medical treatment.

AB - Objective: Evaluation of altered urinary nucleosides before and after tumor removal of breast cancer (BCa). Design and methods: Targeted metabolite profiling of 14 urinary nucleosides was conducted with both pre- and post-operative female patients with BCa (n = 150, age: 46.6 ± 7.7 years), and female controls (n = 150, age: 46.8 ± 7.7 years) by liquid chromatography-tandem mass spectrometry coupled to on-line extraction. Results: Levels of modified nucleosides (5-hydroxymethyl-2′-deoxyuridine, P < 0.001; 8-hydroxy-2′-deoxyguanosine, P < 0.001; 1-methyladenosine, P < 0.02; N2,N2-dimethylguanosine, P < 0.001) were significantly higher in pre-operative patients than in both normal controls and post-operative patients. Conclusions: This approach could be used to further understand the pathogenesis of BCa as well as to evaluate the effects of medical treatment.

UR - http://www.scopus.com/inward/record.url?scp=61849178717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849178717&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2008.12.026

DO - 10.1016/j.clinbiochem.2008.12.026

M3 - Article

C2 - 19186175

AN - SCOPUS:61849178717

VL - 42

SP - 540

EP - 543

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 6

ER -